Human Papillomavirus (HPV)

Cervical cancer is one of the leading causes of cancer-related deaths among women in Latin America and the Caribbean. For example, of the 80,000 new cases and 36,000 cervical cancer deaths reported in the Americas in 2008 alone, Latin American and Caribbean countries accounted for the vast majority.

Late last week, the GAVI Alliance board announced its plan to fund the introduction of vaccine

Sabin Executive Vice-President, Ciro de Quadros, M.D., M.P.H., recently co-authored two new papers that will appear this month in the Strüngmann Forum Report entitled, "Disease Eradication in the 21st Century: Implications for Global Health.” The 

04.14.11 to 04.15.11
Lima, Peru

Price is the Main Barrier to Wider Use of Papillomavirus Vaccine

At its debut 2 years ago, a vaccine that pre-vents cervical cancer was heralded as a public health breakthrough that could poten-tially save millions of women’s lives. Yet although the vaccine is now given routinely to young girls in the United States and Europe, it hasn’t been deployed in poorer countries, where it could make a bigger difference.

Science

Pages

Subscribe to RSS - Human Papillomavirus (HPV)